Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | TH9619 |
| Synonyms | |
| Therapy Description |
TH9619 inhibits MTHFD1 and nuclear MTHFD2, resulting in decreased synthesis of thymidylate and potentially leading to increased apoptosis and tumor cell death (PMID: 37012496) |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| TH9619 | TH 9619|TH-9619 | TH9619 inhibits MTHFD1 and nuclear MTHFD2, resulting in decreased synthesis of thymidylate and potentially leading to increased apoptosis and tumor cell death (PMID: 37012496) |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07151040 | Phase Ib/II | TH9619 | Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors (ODIN) | Recruiting | GBR | FRA | ESP | 0 |